Pfizer’s got its eye on more than the COVID-19 market
May 04, 2022 at 14:28 PM EDT
The company is already laying the groundwork for what it will look like when revenue from its COVID-19 franchise begins to wane.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|